Michael Gray

Michael Gray

Institute of Biomedical Engineering, University of Oxford

Affiliated withUniversity of Oxford

Research Area

Biography

Michael joined the BUBBL group in September 2015 primarily to work on a Phase-1 clinical trial of ultrasound-mediated targeted drug delivery for treatment of liver cancer. His current research efforts include a Phase-1 trial of ultrasound-triggered drug delivery to pancreatic tumours, clinical translation of quantitative cavitation monitoring techniques, and development of devices to enable the use of sound, magnetism, and light for targeted drug delivery.

Michael earned his doctorate from the Georgia Institute of Technology in 2015 after designing and demonstrating an ultrasonic system for deep tissue elastography. Over the preceding 23 years, Michael was a research engineer and principal investigator at Georgia Tech, working in research areas including submarine sonar, cetacean soft tissue characterization, photoacoustics, fish hearing, and non-destructive structural evaluation.

JoVE Journal Publications

ArticleTotal : 1
Year
Studying Cavitation Enhanced Therapy
Publication title

Cited by 6

2021

Other Publications

Article
Year
Is it safe to stop anticoagulants after successful surgery for atrial fibrillation?

Interactive cardiovascular and thoracic surgery| PubMed ID: 21885540

2011
In vivo ultrasonic attenuation in cetacean soft tissues.

The Journal of the Acoustical Society of America| PubMed ID: 28253670

2017
2018
2019
2019
2019
Investigating the Role of Lipid Transfer in Microbubble-Mediated Drug Delivery.

Langmuir : the ACS journal of surfaces and colloids| PubMed ID: 31517490

2019
2019
Magnetic microbubble mediated chemo-sonodynamic therapy using a combined magnetic-acoustic device.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 31733295

2020
Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 31891732

2020
2021
2021
2021
2021